FFCP PHASE2:Hg19::chr1:50570200..50570209,+
From FANTOM5_SSTAR
Revision as of 08:56, 28 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr1:50570200..50570209, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr1:50570200..50570209, + |
Coexpression cluster: | C89_small_retinoblastoma_medulloblastoma_iPS_acantholytic_eye_bronchogenic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr1:50570200..50570209+ |
---|
0
1
2
3
4
5
6
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
sympathetic nervous system | 5.15e-21 | 5 |
autonomic nervous system | 5.15e-21 | 5 |
peripheral nervous system | 2.45e-12 | 8 |
Showing 1 to 3 of 3 entries
Ontology term | p-value | n |
---|---|---|
lung small cell carcinoma | 5.56e-26 | 4 |
neuroendocrine tumor | 9.07e-18 | 6 |
bronchus cancer | 1.65e-15 | 7 |
bronchogenic carcinoma | 1.65e-15 | 7 |
lung carcinoma | 2.19e-12 | 9 |
neuroectodermal tumor | 3.02e-11 | 10 |
lung cancer | 5.55e-08 | 15 |
respiratory system cancer | 1.45e-07 | 16 |
Showing 1 to 8 of 8 entries